Bio-Rad Laboratories (BIO-B) Change in Acquisitions & Divestments (2010 - 2026)

Bio-Rad Laboratories (BIO-B) has 17 years of Change in Acquisitions & Divestments data on file, last reported at $17.7 million in Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $17.7 million, down 9.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $60.2 million (down 94.29% YoY), and the FY2025 annual result was $62.0 million, down 94.39% from the prior year.
• Change in Acquisitions & Divestments grew to $17.7 million in Q1 2026 per BIO-B's latest filing, from -$584.2 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $601.0 million in Q3 2025 and troughed at -$584.2 million in Q4 2025.
• A 5-year average of $120.3 million and a median of $76.1 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
• The sharpest annual moves came in 2022 and 2025: Change in Acquisitions & Divestments soared 12169.9% in 2022, then plunged 384.28% in 2025.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $65.1 million in 2022, then soared by 150.28% to $162.9 million in 2023, then gained by 26.18% to $205.5 million in 2024, then sank by 384.28% to -$584.2 million in 2025, then soared by 103.03% to $17.7 million in 2026.
• Business Quant data shows BIO-B's Change in Acquisitions & Divestments at $17.7 million in Q1 2026, -$584.2 million in Q4 2025, and $601.0 million in Q3 2025.